VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $268,000 | -19.5% | 1,500 | 0.0% | 0.04% | -24.1% |
Q2 2015 | $333,000 | +11.7% | 1,500 | 0.0% | 0.06% | +7.4% |
Q1 2015 | $298,000 | -9.4% | 1,500 | -34.8% | 0.05% | -21.7% |
Q4 2014 | $329,000 | +8.9% | 2,300 | 0.0% | 0.07% | +19.0% |
Q3 2014 | $302,000 | +4.1% | 2,300 | 0.0% | 0.06% | +7.4% |
Q2 2014 | $290,000 | -4.3% | 2,300 | 0.0% | 0.05% | -6.9% |
Q1 2014 | $303,000 | +12.2% | 2,300 | 0.0% | 0.06% | +7.4% |
Q4 2013 | $270,000 | -28.2% | 2,300 | -36.1% | 0.05% | -32.5% |
Q3 2013 | $376,000 | +21.3% | 3,600 | 0.0% | 0.08% | +23.1% |
Q2 2013 | $310,000 | – | 3,600 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |